Galderma R&D Clinical Trials
Sponsors / Galderma R&D
302 ClinicalTrials.gov entries name Galderma R&D as the lead sponsor. The portfolio currently includes 11 recruiting studies, 7 active non-recruiting studies, and 267 completed studies. 7 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, business or strategic decisions. Cumulative planned enrollment across all listed trials is 62,806 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
302
Total Trials
11
Recruiting
7
Other Active
267
Completed
7
Terminated / Withdrawn
62,806
Total Enrollment
Termination reasons: Other57% · Recruitment29% · Business14%
Recent Terminations
- Keratosis, Actinic"The study was terminated early as per Sponsor's decision"
- Capillary Malformations"Poor enrollment, lack of feasibility"
- Facial Tissue Augmentation"Sponsor business reasons"
- Erythema and Flushing Associated With Rosacea"sponsor asked site to suspend study."
- Knee Osteoarthritis"Study terminated early due to decision by sponsor"
- Melasma"Enrollment closed"
- Nasolabial Folds"Sponsor decision"
Active Trials (7 total)
- NCT07074977
- NCT06988605
- NCT06988618
- NCT07047638
- NCT07399028
- NCT07342400
- NCT07324564
- NCT04341623
- Perioral Wrinkles PHASE4NCT07225348
- Acne Vulgaris PHASE3NCT07186413
- Prurigo Nodularis PHASE3NCT04204616
- Photoaging NANCT06195605
- NCT05987163
- NCT06656923
- NCT03713203
- NCT06665477
- NCT03989206
- Aging NANCT04162496